"Saint Joseph Mercy Health System (SJMHS) is a health care organization serving seven counties in southeast Michigan including Livingston, Washtenaw, Wayne, Oakland, Macomb, Jackson, and Lenawee. It includes 548-bed St. Joseph Mercy Ann Arbor, 497-bed St. Joseph Mercy Oakland in Pontiac, 304-bed St. Mary Mercy Livonia, 66-bed St. Joseph Mercy Livingston in Howell, and 133-bed St. Joseph Mercy Chelsea."

During the past decade, Saint Joseph Mercy Brighton conducted 173 clinical trials. In the 10-year time frame, 173 clinical trials started and 37 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 92 clinical trials started and 36 clinical trials were completed. i.e. 39.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph Mercy Brighton" #1 sponsor was "National Cancer Institute (NCI)" with 88 trials, followed by "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "SWOG Cancer Research Network" with 32 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Mercy Brighton" #1 collaborator was "National Cancer Institute (NCI)" with 96 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph Mercy Brighton" are "Stage IV Lung Cancer AJCC v8" (15 trials), "Stage IVA Lung Cancer AJCC v8" (10 trials), "Stage IVB Lung Cancer AJCC v8" (10 trials), "Recurrent Lung Non-Small Cell Carcinoma" (8 trials) and "Invasive Breast Carcinoma" (7 trials). Many other conditions were trialed in "Saint Joseph Mercy Brighton" in a lesser frequency.

Most popular intervention types in "Saint Joseph Mercy Brighton" are "Drug" (148 trials), "Other" (115 trials), "Biological" (69 trials), "Procedure" (58 trials) and "Radiation" (34 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (63 trials), "Questionnaire Administration" (46 trials), "Biospecimen Collection" (36 trials), "Computed Tomography" (35 trials) and "Laboratory Biomarker Analysis" (35 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph Mercy Brighton" are 168 trials for "All" genders, 17 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph Mercy Brighton". undefined are not yet recruiting, 83 are recruiting, 77 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Saint Joseph Mercy Brighton, 9 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph Mercy Brighton, 3 "Phase 1" clinical trials were conducted, 98 "Phase 2" clinical trials and 101 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".